Abstract: EGFR-binding modular recognition domains (MRDs) and complexes containing such MRDs linked to antibodies are described. The use of such MRDs and complexes are also described.
Type:
Grant
Filed:
March 14, 2014
Date of Patent:
December 11, 2018
Assignee:
Zyngenia, Inc.
Inventors:
Viktor Roschke, David Lafleur, David M. Hilbert, Peter Kiener
Abstract: Complexes containing one or more modular recognition domains (MRDs) and MRDs attached to scaffolds including antibodies are described. The manufacture of these complexes are the use of these complexes to treat and diagnose diseases and disorders are also described.
Type:
Grant
Filed:
May 8, 2017
Date of Patent:
October 2, 2018
Assignee:
Zyngenia, Inc.
Inventors:
Viktor Roschke, David Lafleur, David M. Hilbert, Peter Kiener
Abstract: Complexes containing one or more modular recognition domains (MRDs) and MRDs attached to scaffolds including antibodies are described. The manufacture of these complexes are the use of these complexes to treat and diagnose diseases and disorders are also described.
Type:
Grant
Filed:
October 29, 2014
Date of Patent:
June 13, 2017
Assignee:
Zyngenia, Inc.
Inventors:
Viktor Roschke, David Lafleur, David M. Hilbert, Peter Kiener
Abstract: Compositions containing multivalent and monovalent multispecific complexes having scaffolds such as antibodies that support such binding functionalities are described. The use of and methods of compositions containing multivalent and monovalent multispecific complexes having scaffolds, such as antibodies, that support such binding functionalities are also described.
Type:
Application
Filed:
September 9, 2014
Publication date:
July 30, 2015
Applicant:
ZYNGENIA, INC.
Inventors:
VIKTOR ROSCHKE, DAVID LAFLEUR, DAVID M. HILBERT, PETER KIENER
Abstract: Monovalent and multivalent multispecific complexes including ELP-MRD fusion proteins containing one or more modular recognition domains (MRDs) that bind target antigens are described. The use of these monovalent and multivalent multispecific complexes (e.g., ELP-MRD fusion proteins) in diagnostic, prognostic, and therapeutic applications and methods of making these complexes are also described.
Abstract: Compositions containing multivalent and monovalent multispecific complexes having scaffolds such as antibodies that support such binding functionalities are described. The use of and methods of compositions containing multivalent and monovalent multispecific complexes having scaffolds, such as antibodies, that support such binding functionalities are also described.
Type:
Application
Filed:
March 15, 2013
Publication date:
March 6, 2014
Applicant:
Zyngenia, Inc.
Inventors:
Viktor ROSCHKE, David Lafleur, David M. Hilbert, Peter Kiener
Abstract: Monovalent and multivalent multispecific complexes including ELP-MRD fusion proteins containing one or more modular recognition domains (MRDs) that bind target antigens are described. The use of these monovalent and multivalent multispecific complexes (e.g., ELP-MRD fusion proteins) in diagnostic, prognostic, and therapeutic applications and methods of making these complexes are also described.
Abstract: Complexes containing one or more modular recognition domains (MRDs) and MRDs attached to scaffolds including antibodies are described. The manufacture of these complexes are the use of these complexes to treat and diagnose diseases and disorders are also described.
Type:
Application
Filed:
July 15, 2011
Publication date:
April 26, 2012
Applicant:
Zyngenia, Inc.
Inventors:
Viktor Roschke, David Lafleur, David M. Hilbert, Peter Kiener